Glenmark Pharma hits 52-week low on subdued Q4 results
The stock hit a fresh 52-week low of Rs 484, slipped 9% on the BSE in early morning trade, after the company reported 17% decline in its consolidated net profit at Rs 1.52 billion in March quarter.
br> The stock hit a fresh 52-week low of Rs 484, slipped 9% on the BSE in early morning trade, after the company reported 17% decline in its consolidated net profit at Rs 1.52 billion in March quarter. https://ift.tt/2xn3yqc May 29, 2018 at 07:17PM
br> The stock hit a fresh 52-week low of Rs 484, slipped 9% on the BSE in early morning trade, after the company reported 17% decline in its consolidated net profit at Rs 1.52 billion in March quarter. https://ift.tt/2xn3yqc May 29, 2018 at 07:17PM
Comments
Post a Comment